IC
HAE icon

IEQ Capital’s Haemonetics HAE Stock Holding History

IEQ Capital’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3M Sell
17,295
-3,703
-18% -$238K 0.01% 995
2026
Q1 		$1.18M Sell
20,998
-9,326
-31% -$607K 0.01% 968
2025
Q4 		$2.43M Buy
30,324
+25,887
+583% +$1.74M 0.01% 729
2025
Q3 		$216K Buy
+4,437
New +$275K ﹤0.01% 1654

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IEQ Capital's HAE Position: Q2 2026 in Review

IEQ Capital reduced its Haemonetics (HAE) stake by 18% in Q2 2026, selling an estimated $238K and leaving 17,295 shares worth $1.3M. The position accounts for 0.01% of the portfolio, ranked #995.

IEQ Capital first reported a position in HAE in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.43M in Q4 2025. 330 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • IEQ Capital held 17,295 shares of Haemonetics worth $1.3M as of Q2 2026.
  • IEQ Capital sold 3,703 Haemonetics shares in Q2 2026, an estimated $238K.
  • Haemonetics made up 0.01% of IEQ Capital's portfolio in Q2 2026, its #995 holding.
  • IEQ Capital first reported a position in Haemonetics in Q3 2025 and has held it in 4 quarters since.
  • IEQ Capital's Haemonetics position peaked at $2.43M in Q4 2025.
  • 330 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.